| |
|
Form Serial Number: |
CS20260623E00379 |
| 1.
Date of relevant event: |
16/06/2026
(dd/mm/yyyy)
|
| 2.
Date when the substantial shareholder becomes aware of the relevant event / interest in the shares (if later): |
18/06/2026
(dd/mm/yyyy)
|
| 3.
Stock code: |
01187 |
| 4.
Name of listed corporation: |
Cofoe Medical Technology Co., Ltd. - H Shares |
| 5.
Class of shares: |
A Shares |
| 6.
Number of issued shares in class: |
208,897,000 |
| 7.
Name of substantial shareholder: |
长沙械字号医疗投资有限公司 |
| 8.
Registered office: |
长沙市雨花区振华路199号湖南环保科技产业园创业中心101（546）室 |
| 9.
Principal place of business in Hong Kong: |
无 |
| 15.
Exchange on which listed: |
|
| 16.
Name of listed parent and exchange on which parent is listed: |
|
|
| 17.
Details of relevant event: |
|
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved |
Currency of transaction |
On Exchange
|
Off Exchange
|
| Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Nature of consideration
|
|
Long position |
| 1305 | There has been a change in nature of your interest in the shares because:
you have provided an interest in the shares as security to a person other than a qualified lender |
|
|
|
8,000,000 |
|
|
|
|
|
| Short position |
|
|
|
|
|
|
|
|
|
|
|
| 18.
Total shares immediately before the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 85,079,923 | 40.73 |
|
|
| 19.
Total shares immediately after the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 85,079,923 | 40.73 |
|
|
| 20.
Capacity in which interests disclosed in Box 19 are held: |
| Capacity code | Number of shares |
| |
|
|
|
|
| 21.
Further information in respect of derivative interests: |
| Derivatives code | Number of shares |
| | |
|
|
| 22.
Further information in relation to interests of corporations controlled by substantial shareholder: |
| Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
| | | | | |
|
|
|
| 23.
Further information in relation to interests held by substantial shareholder jointly with another person: |
| Name of joint shareholder | Address | Number of shares |
| | |
|
|
| 24.
Further information from a trustee, a beneficiary of a trust, or a person who set up a discretionary trust: |
| Names of trust | Address | Status code | Number of shares |
| | | |
|
|
| 25.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
| Names of other parties | Address | Number of shares |
| | |
| Total number of shares in which a substantial shareholder is interested under sections 317 and 318 | |
|
|
| 26.
Details of person(s) in accordance with whose directions the substantial shareholder or its directors are accustomed to act: |
| Names | Address | Relationship Code | Percentage (%) |
| | | |
|
| |
| 27.
Supplementary information: |
方格17長沙械字號於2026年6月16日以長沙農村商業銀行股份有限公司梓園支行(「質權人」，按照《銀行業條例》(香港法例第155章)界定為認可機構)為受惠人，質押其持有的8,000,000股上市公司A股股份(約佔上市公司已發行股本總額3.39%)，作為其真誠商業貸款的擔保。詳情可參閱上市公司於2026年6月18日發佈的公告。
|
| 28.
Log/Serial Number of the previous form: |
|
| 29.
Number of concert party document(s) under section 317 attached/uploaded: |
|
|
Date of filing this Form 2: |
23/06/2026
(dd/mm/yyyy)
|
|
|
|
|